Comanche Biopharma Announces European Medicines Agency (EMA) Has Granted Orphan Drug Designation for CBP-4888 in sFlt1-mediated Preterm Preeclampsia
EMA orphan drug designation is awarded to drugs intended to treat rare diseases that are life-threatening or chronically ...